| Ytd | -63.76% | |
| 1y | -40.82% |
| Open | 0.45 | Prev Close | 0.44 | Low | 0.45 | High | 0.47 | Mkt Cap | 15.62M |
| Vol | 60.59K | Avg Vol | 225.69K | EPS | -1.67 | P/E | N/A | Forward P/E | -3.75 |
| Beta | 0.82 | Short Ratio | 0.32 | Inst. Own | 2.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-16 | 50-d Avg | 0.50 | 200-d Avg | 0.68 | 1yr Est | 2.00 |
KTTA News
Pasithea Therapeutics Corp. (NASDAQ: KTTA - Get Free Report) shares dropped 2.7% on Friday. The comp
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark
Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session
-- Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of PAS-004, a Macrocyclic MEK In
Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-
HC Wainwright & Co. analyst Sara Nik reiterates Pasithea Therapeutics (NASDAQ:KTTA) with a Bu
-- Remains on track to release interim NF1 data update in Q4 2026 ---- Additional dose levels and lo
Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1145326
Pasithea Therapeutics (NASDAQ:KTTA) reported quarterly losses of $(0.12) per share which beat the an
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company p
On Thursday, 185 companies achieved new lows for the year.
On Monday, 89 stocks made new 52-week lows.
On Friday, 469 companies hit new 52-week lows.
On Monday, 198 companies hit new 52-week lows.
On Wednesday, 479 stocks made new 52-week lows.